[Venous thrombembolism in tumour patients].
Standard
[Venous thrombembolism in tumour patients]. / Pabinger, I; Alt-Epping, B; Demarmels Biasutti, F; Langer, Florian; Wörmann, B; Riess, H.
in: HAMOSTASEOLOGIE, Jahrgang 31, Nr. 4, 4, 2011, S. 281-282.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Venous thrombembolism in tumour patients].
AU - Pabinger, I
AU - Alt-Epping, B
AU - Demarmels Biasutti, F
AU - Langer, Florian
AU - Wörmann, B
AU - Riess, H
PY - 2011
Y1 - 2011
N2 - Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft für Thrombose- und Hämostaseforschung, the Deutsche Gesellschaft für Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.
AB - Venous thrombembolism (VTE) is one of the most frequent complication in cancer patients. The current options in prophylaxis and therapy have to be balanced against the risks of major bleeding and the burden for the patients. The Gesellschaft für Thrombose- und Hämostaseforschung, the Deutsche Gesellschaft für Palliativmedizin and the German speaking Societies of Hematology and Oncology have recently published guidelines on VTE in cancer patients. Recommendations include diagnostics, individual prophylaxis and treatment.
KW - Humans
KW - Anticoagulants/administration & dosage/adverse effects
KW - Hemorrhage/chemically induced/prevention & control
KW - Neoplasms/complications/therapy
KW - Venous Thromboembolism/etiology/therapy
KW - Humans
KW - Anticoagulants/administration & dosage/adverse effects
KW - Hemorrhage/chemically induced/prevention & control
KW - Neoplasms/complications/therapy
KW - Venous Thromboembolism/etiology/therapy
M3 - SCORING: Zeitschriftenaufsatz
VL - 31
SP - 281
EP - 282
JO - HAMOSTASEOLOGIE
JF - HAMOSTASEOLOGIE
SN - 0720-9355
IS - 4
M1 - 4
ER -